Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multiantigen-specific T-cell transfer after allogeneic stem cell transplantation
NL-OMON25777Phase 2Not yet recruiting
- Sponsor
- Leiden University Medical Center
- Start
- Oct 2014
- Countries
- 1
01
Overview
Phase 2, open-label trial in hematopoietic malignancies, acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML) and 9 more (2 cohorts), sponsored by Leiden University Medical Center. Primary endpoint: Immunologic efficacy. Planned start Oct 2014; status: not yet recruiting.
02
Conditions
hematopoietic malignanciesacute lymphoblastic leukemia (ALL)acute myeloid leukemia (AML)multiple myeloma (MM)mature B-cell lymphoma
Beyond the preview
Go deeper on NL-OMON25777.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON25777.